John Marotta sold $9,294 of AZTA
President and CEO at Azenta, Inc.. 316 shares at an average of $29.41, traded Sep 10, 2025, filed Sep 12, 2025.
Score components
- +25RoleCEO
- 0Trade size$9k at market
- 0Share of holdings soldSold 0.3% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-114528, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 10, 2025 | SOpen-market sale Common | -316 | $29.41 | $9,294 | 105,980 | Sep 12, 2025 |
Related signals
Other insiders at Azenta, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | AZTAbuy Azenta, Inc. | Lawrence Y. Lin EVP, CFO and Treasurer | $70k 2,500 shares | +6% | |
| 15Weak | AZTAbuy Azenta, Inc. | Ginger Zhou SVP and General Manager, Genom | $19k 417 shares | +2% | |
| 15Weak | AZTAsell Azenta, Inc. | Violetta Hughes VP, Chief Accounting Officer | $17k 317 shares | -3% | |
| 42Moderate | Azenta, Inc. | Herman Cueto EVP, Chief Financial Officer | $29k 712 shares | -3% | |
| 36Weak | Azenta, Inc. | Jason Joseph SVP, General Counsel, Secy. | $46k 1,139 shares | -1% | |
| 30Weak | Azenta, Inc. | David Dong Wang SVP & GM, SMS | $14k 348 shares | -1% | |
| 30Weak | Azenta, Inc. | Ginger Zhou SVP and General Manager, Genom | $20k 491 shares | -2% | |
| 30Weak | Azenta, Inc. | Violetta Hughes VP, Chief Accounting Officer | $6,531 163 shares | -2% | |
| 30Weak | Azenta, Inc. | Olga Pirogova SVP and CHRO | $22k 548 shares | -3% | |
| 52Moderate | Azenta, Inc. | Martin D Madaus Interim CEO | $201k 4,940 shares | +200% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.